Filter News
Area of Research
- (-) National Security (3)
- (-) Supercomputing (19)
- Biological Systems (1)
- Biology and Environment (29)
- Clean Energy (10)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (1)
- Isotopes (6)
- Materials (7)
- Materials for Computing (2)
- Neutron Science (12)
- Nuclear Science and Technology (2)
News Topics
- (-) Biomedical (17)
- (-) Biotechnology (3)
- 3-D Printing/Advanced Manufacturing (7)
- Advanced Reactors (2)
- Artificial Intelligence (45)
- Big Data (23)
- Bioenergy (11)
- Biology (14)
- Buildings (4)
- Chemical Sciences (5)
- Climate Change (20)
- Computer Science (104)
- Coronavirus (16)
- Critical Materials (3)
- Cybersecurity (23)
- Decarbonization (6)
- Energy Storage (9)
- Environment (25)
- Exascale Computing (24)
- Frontier (29)
- Fusion (2)
- Grid (11)
- High-Performance Computing (42)
- Isotopes (2)
- Machine Learning (23)
- Materials (16)
- Materials Science (17)
- Mathematics (1)
- Microscopy (7)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (36)
- Net Zero (1)
- Neutron Science (15)
- Nuclear Energy (8)
- Partnerships (5)
- Physics (9)
- Polymers (2)
- Quantum Computing (19)
- Quantum Science (25)
- Security (14)
- Simulation (15)
- Software (1)
- Space Exploration (3)
- Summit (43)
- Sustainable Energy (12)
- Transportation (8)
Media Contacts
A team of computational scientists at ORNL has generated and released datasets of unprecedented scale that provide the ultraviolet visible spectral properties of over 10 million organic molecules.
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
Hilda Klasky, an R&D staff member in the Scalable Biomedical Modeling group at ORNL, has been selected as a senior member of the Association of Computing Machinery, or ACM.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
ORNL scientists had a problem mapping the genomes of bacteria to better understand the origins of their physical traits and improve their function for bioenergy production.
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from ORNL developed a novel technique.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.